The association between smoking and the prevalence of intermittent claudication

Vascular Medicine

Volumn 10, Issue 4, 2005, Pages 257-263

  Jensen, Svein A ^a   Vatten, Lars J ^a   Nilsen, Tom I L ^a   Romundstad, Pål R ^a   Myhre, Hans O ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Epidemiology; Intermittent claudication; Passive smoking; Prevalence; Smoking

Indexed keywords

ADULT; AGE; AGED; ALGORITHM; ANKLE BRACHIAL INDEX; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LOGISTIC REGRESSION ANALYSIS; MALE; MATHEMATICAL COMPUTING; NORWAY; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING CESSATION; SMOKING HABIT;

ADULT; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; NORWAY; PREVALENCE; REGRESSION ANALYSIS; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO SMOKE POLLUTION;

EID: 31344455924     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x05vm635oa     Document Type: Article

References (28)

1. Jensen SA, Vatten LJ, Romundstad PR, Myhre HO. The prevalence of intermittent claudication. Sex-related differences have been eliminated. Eur J Vasc Endovasc Surg 2003; 25: 209-12.
2. Tierney S, Fennessy F, Bouchier-Hayes D. ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 2000; 320: 1262-65.
3. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105.
4. Bouchier-Hayes D. Secondary prevention of peripheral arterial disease. Critical Ischaemia 2001; 11: 37-44.
5. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull Org Mond Santé 1962; 27: 645-58.
6. Holmen J, Midthjell K, Krüger Ø et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13: 19-32.
7. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-109.
8. Jensen SA, Vatten LJ, Romundstad PR, Myhre HO. The prevalence of asymptomatic arterial obstruction in the lower extremities among men and women 60 to 69 years of age. Int Angiol 2003; 22: 340-43.
9. Fowkes FG, Housley E, Cawood EH et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-92.
10. Criqui MH, Fronek A, Klauber MR et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population, Circulation 1985; 71: 516-22.
11. National Institutes of Health, National Heart and Lung Institute. Manual of laboratory operations: lipid research clinics program. Lipid and Lipoprotein Analysis 1975; 1: 75-628.
12. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977; 31: 42-48.
13. Powell JT, Edwards RJ, Worrell PC et al. Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study. Atherosclerosis 1997; 129: 41-48.
14. Kannel WB, Skinner JJ, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation 1970; 41: 875-83.
15. Bothig S, Metelitsa VI, Barth W et al. Prevalence of ischaemic heart disease, arterial hypertension and intermittent claudication, and distribution of risk factors among middle-aged men in Moscow and Berlin. Cor Vasa 1976; 18: 104-18.
16. Scholl M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurement in a population study of 60-year-old men and women. J Chron Dis 1981; 34: 261-69.
17. Fowkes FG, Housley E, Riemersma RA et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992; 135: 331-40.
18. Dormandy J, Heeck L, Vig S. Intermittent claudication: a condition with underrated risks. Semin Vasc Surg 1999; 12: 96-108.
19. Werner RM, Pearson TA. What's so passive about passive smoking? Secondhand smoke as a cause of atherosclerotic disease. JAMA 1998; 279: 157-58.
20. Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation 1991; 83: 1-12.
21. Willigendael EM, Teijink JA, Bartelink ML et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004; 40: 1158-65.
22. Wells AJ, English PB, Posner SF et al. Misclassification rates for current smokers misclassified as nonsmokers. Am J Public Health 1998; 88: 1503-509.
23. Rebagliato M. Validation of self reported smoking. J Epidemiol Community Health 2002; 56: 163-64.
24. Smith I, Franks PJ, Greenhalgh RM et al. The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg 1996; 11: 402-408.
25. Quick CR, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982; 69(suppl): S24-S26.
26. Widmer LK. Organisation der Basler Studie über Arterien-, Venen- und Herzkrankenheit. [The organization of the Basel Studies on arterial, venous and heart disease.] Schweiz Med Wochenschr 1967; 97(4): 99-102 (Ges).
27. Palmer-Kazen U, Wahlberg E. Arteriogenesis in peripheral arterial disease. Endothelium 2003; 10: 225-32.
28. Wiggers LC, Smets EM, de Haes JC et al. Smoking cessation interventions in cardiovascular patients. Eur J Vasc Endovasc Surg 2003; 26: 467-75.